Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $4.72 in the prior trading day, CuriosityStream Inc (NASDAQ: CURI) closed at $4.82, up 2.12%. In other words, the price has increased by $2.12 from its previous closing price. On the day, 0.51 million shares were traded. CURI stock price reached its highest trading level at $4.9649 during the session, while it also had its lowest trading level at $4.8.
Ratios:
Our goal is to gain a better understanding of CURI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.12. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Craig Hallum on August 18, 2025, initiated with a Buy rating and assigned the stock a target price of $7.
On May 07, 2025, Barrington Research Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 12 ’25 when HUBERMAN JONATHAN sold 50,000 shares for $4.75 per share. The transaction valued at 237,500 led to the insider holds 1,233,576 shares of the business.
HUBERMAN JONATHAN sold 25,000 shares of CURI for $112,500 on Sep 11 ’25. The Director now owns 1,283,576 shares after completing the transaction at $4.50 per share. On Sep 12 ’25, another insider, HUBERMAN JONATHAN, who serves as the Director of the company, bought 50,000 shares for $4.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CURI now has a Market Capitalization of 279221312 and an Enterprise Value of 255178320. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.59 while its Price-to-Book (P/B) ratio in mrq is 5.58. Its current Enterprise Value per Revenue stands at 4.194 whereas that against EBITDA is 25.042.
Stock Price History:
The Beta on a monthly basis for CURI is 1.86, which has changed by 1.1327434 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, CURI has reached a high of $7.01, while it has fallen to a 52-week low of $1.44. The 50-Day Moving Average of the stock is 2.97%, while the 200-Day Moving Average is calculated to be 25.00%.
Shares Statistics:
The stock has traded on average 632.74K shares per day over the past 3-months and 489750 shares per day over the last 10 days, according to various share statistics. A total of 57.71M shares are outstanding, with a floating share count of 39.27M. Insiders hold about 32.21% of the company’s shares, while institutions hold 20.58% stake in the company. Shares short for CURI as of 1759190400 were 2399619 with a Short Ratio of 3.79, compared to 1756425600 on 1859347. Therefore, it implies a Short% of Shares Outstanding of 2399619 and a Short% of Float of 7.140000000000001.
